HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-783X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma ; volume:21 ; number:1 ; day:24 ; month:6 ; year:2016 ; pages:1-6 ; date:12.2016
European journal of medical research ; 21, Heft 1 (24.6.2016), 1-6, 12.2016
- Creator
-
Buurman, Reena
- Contributor
-
Sandbothe, Maria
Schlegelberger, Brigitte
Skawran, Britta
SpringerLink (Online service)
- DOI
-
10.1186/s40001-016-0217-x
- URN
-
urn:nbn:de:1111-2016082911617
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Buurman, Reena
- Sandbothe, Maria
- Schlegelberger, Brigitte
- Skawran, Britta
- SpringerLink (Online service)
Other Objects (12)
Epigenetische Regulierung und HDAC Inhibition von kolorektalen Karzinomen
HDAC inhibition ameliorates cone survival in retinitis pigmentosa mice
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
Carbamates as potential prodrugs and a new warhead for HDAC inhibition
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
TAZ2 truncation confers overactivation of p300 and cellular vulnerability to HDAC inhibition
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression
Epigenetische Regulierung und HDAC Inhibition von kolorektalen Karzinomen
HDAC inhibition ameliorates cone survival in retinitis pigmentosa mice
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
Carbamates as potential prodrugs and a new warhead for HDAC inhibition
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
TAZ2 truncation confers overactivation of p300 and cellular vulnerability to HDAC inhibition
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression
Epigenetische Regulierung und HDAC Inhibition von kolorektalen Karzinomen
HDAC inhibition ameliorates cone survival in retinitis pigmentosa mice
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
Carbamates as potential prodrugs and a new warhead for HDAC inhibition
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
TAZ2 truncation confers overactivation of p300 and cellular vulnerability to HDAC inhibition
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma